Chinese health industry 2019 white paper: four dimensions predict the next explosion point

With the rapid progress of science and technology, especially the arrival of artificial intelligence and 5g era, we are ushering in a new dawn of "centenary era" The extension of health industry is expanding, and the integration of adjacent industries is accelerating New players will flow in from all directions All kinds of medical and health services and medical and nursing services will emerge as the times require In addition to basic medical services, those medical and health services that focus on maintaining vigorous vitality, young appearance and health status, and improving the quality of life of "new elderly" will form a huge market This is the judgment from the 2019 white paper of China's health industry issued by e-capital Recently, Yikai capital released the 2019 white paper on China's health industry (hereinafter referred to as the white paper) Focusing on the topics of medicine and biotechnology, medical technology and medical devices, medical services, digital medicine and so on, the white paper was released on-site to discuss the future of China's health industry Biopharmaceutical technology will continue to be sought after by capital in pharmaceutical research and development, and China is gradually integrating with the world According to the white paper, the breakthrough of new technology of global biomedicine is gradually turning the once incurable diseases such as cancer into chronic diseases Many gene therapy programs and drugs have been approved overseas, which brings the revolution of disease treatment means and indicates the arrival of the era of precision treatment The integration of diagnosis and treatment is the basic feature of future precision medicine, and the breakthrough of disease diagnosis technology is the key to improve the treatment effect and survival rate of patients At the same time, major regulators around the world, including the United States and China, are trying to speed up the approval of new drugs It is expected that more new drugs will be approved and listed quickly by adopting new clinical endpoints in the future Globally, biopharmaceutical start-ups continue to be sought after by capital The average stage of biopharmaceutical start-ups in the US IOP is becoming more and more early The science and technology innovation board also launched in the mainland of China provides more choices for startups in the field of innovative drugs to enter the capital market in the future Cancer early screening technology will reach a trillion scale in the field of medical technology and medical devices According to the white paper, cancer early screening is a technology that can really change the pattern of cancer treatment Through early detection, diagnosis and treatment of cancer, cancer mortality can be greatly reduced It is not expected to reach a trillion scale market Therefore, if a company like Tencent is born in the gene field, it is likely to grow from the early screening market In terms of medical devices, domestic and foreign medical device regulatory ideas are moving towards a rational innovation stage, drainage and diversion, elimination of the old and promote the steady follow-up of medical device products, and constantly meet the rapidly changing clinical needs "Internet plus medical" will become a new pattern of medical services The turning point of domestic demographic dividend is approaching, the aging trend of population and the decreasing trend of fertility rate are more and more obvious, and medical demand is continuously strong China's population over 60 years old will grow from 240 million today to 480 million in 2050, which will greatly affect the market demand and service structure of China's medical and health services According to the white paper, in the next few years, topics such as hierarchical diagnosis and treatment, chronic disease management, chronic disease and health care will help to alleviate the contradiction between medical supply and demand caused by aging will become a hot topic of social concern In China, the policy of medical reform has been released intensively, and the reform has entered the "deep water area" The establishment of "super medical insurance bureau" which integrates payment, pricing, procurement and supervision, makes the discourse power of medical service payment end unprecedented centralized, reflecting the transformation of "from coarse to fine" in the future of medical reform The implementation of hierarchical diagnosis and treatment, internet medical and other policies has enriched the residents' medical choice, effectively alleviated the problem of "difficult to see a doctor", while the implementation of policies such as volume purchase and drug price negotiation has further reduced the drug price, helping to alleviate the problem of "expensive to see a doctor" China's Internet plus dividend will prompt the Internet game player to deploy new healthcare players in the field of health care Internet plus medical care will completely change the way of treatment and industry in China On the international side, the integration of providers and payers of medical services is intensified worldwide, and controlling medical expenses is still the primary problem in various countries Large commercial insurance companies strengthen their own supervision of medical service expenditure through vertical integration with drug retail institutions and medical service institutions, so as to reduce the high medical cost caused by overuse and overhospitalization In the 5g era, the hospital connection mode will be reconstructed in the field of digital medicine According to the white paper, medical and health big data will be further opened, shared and fully integrated with AI It will be widely used in intelligent diagnosis, clinical decision support, precision treatment and health management in the future to provide doctors and patients with more accurate diagnosis and diagnosis services In the coming 5g era, the connection between doctors and patients will be completely reconstructed, which provides more possibilities for remote diagnosis and intelligent diagnosis and treatment Based on China's population base and social management system, China is likely to become a global health data superpower, and gradually develop into the biggest beneficiary and leader in the era of global data diagnosis and treatment.